Article
A TEM-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy - 1 Nov 1996
Mugnier P, Dubrous P, Casin I, Arlet G, Collatz E
Abstract excerpt
A clinical strain of Pseudomonas aeruginosa, PAe1100, was found to be resistant to all antipseudomonal beta-lactam antibiotics and to aminoglycosides, including gentamicin, amikacin, and isepamicin. PAe1100 produced two beta-lactamases, TEM-2 (pI 5.6) and a novel, TEM-derived extended-spectrum be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
